Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Cosmos Health Inc (NQ: COSM ) 1.140 -0.100 (-8.06%) Streaming Delayed Price Updated: 4:00 PM EDT, Jul 22, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 473,414 Open 1.200 Bid (Size) 1.110 (1) Ask (Size) 1.120 (5) Prev. Close 1.240 Today's Range 1.110 - 1.220 52wk Range 0.4677 - 2.050 Shares Outstanding N/A Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News Cosmos Health's Cana Secures Additional Contract Manufacturing Agreement with Provident Pharmaceuticals for 700,000 Units, Bringing Total Order Book to 5.02 Million Units July 18, 2024 Via ACCESSWIRE Cosmos Health Regains Compliance with Nasdaq Minimum Bid Price Rule July 18, 2024 Via ACCESSWIRE Performance YTD -16.79% -16.79% 1 Month +69.11% +69.11% 3 Month +132.18% +132.18% 6 Month +12.87% +12.87% 1 Year -35.59% -35.59% More News Read More Cosmos Health Advances Commercialization of CCX0722 Weight Management Solution with Completion of Pilot Production and Scale-Up Phases; Significant Step Towards Entering $143Bn Global Market July 10, 2024 Via ACCESSWIRE Cosmos Health's Cana Secures Contract Manufacturing Agreement with Australia's Humacology for up to 500,000 CBD Units Annually July 09, 2024 Via ACCESSWIRE Cosmos Health's Cana Laboratories Completes Facility Upgrades and Secures Contract Manufacturing Agreement with Provident Pharmaceuticals for 4.32 Million Vials of DE3-SOLE July 02, 2024 Via ACCESSWIRE Cosmos Health Expands Collaboration with Papaellinas in Cyprus; Sky Premium Life Sales Expected to More Than Double to 150,000 Units Over Next 12 Months July 02, 2024 Via ACCESSWIRE Cosmos Health Signs Distribution Agreement with ZENDON s.r.o. in Slovakia, Hungary, Poland, and Czechia for Its Sky Premium Life Nutraceutical Products; Gains Access to More than 6,000 Stores of Leading Pharmacy and Retail Chains July 01, 2024 Via ACCESSWIRE Why Cosmos Health Stock Is Trading Higher Friday June 28, 2024 Via Benzinga Why Is Elicio Therapeutics (ELTX) Stock Down 36% Today? June 28, 2024 Via InvestorPlace Why Is Nexalin Technology (NXL) Stock Down 35% Today? June 28, 2024 Via InvestorPlace Why Is Cosmos Health (COSM) Stock Up 65% Today? June 28, 2024 Via InvestorPlace Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday June 28, 2024 Via InvestorPlace Cosmos Health Signs Exclusive Distribution Agreement with Pharmalink for Its Sky Premium Life Nutraceuticals in the UAE; Receives Initial Purchase Order for 130,000 Units June 27, 2024 Via ACCESSWIRE Cosmos Health Strengthens Global Brain Tumor Market Position by Entering Agreement to Acquire Remaining Rights to WIPO-Filed CNS Cancer Drug Patent June 18, 2024 Via ACCESSWIRE Cosmos Health Completes Acquisition of Pelofarm's Pharmacy Distribution Network; Annual Revenue Poised to Grow by Over $5 Million June 13, 2024 Via ACCESSWIRE 12 Health Care Stocks Moving In Thursday's After-Market Session May 30, 2024 Via Benzinga Cosmos Health Receives Additional Delinquency Letter from Nasdaq Regarding Late Filings of Its Forms 10-K and 10-Q May 24, 2024 Via ACCESSWIRE Cosmos Health Participated in Vitafoods Europe 2024; Receives Significant Interest and Numerous New Partnership Inquiries for its Sky Premium Life Nutraceuticals Brand May 17, 2024 Via ACCESSWIRE Stock Market Crash Warning: Don’t Get Caught Holding These 3 Healthcare Stocks April 30, 2024 Via InvestorPlace 12 Health Care Stocks Moving In Monday's After-Market Session April 29, 2024 Via Benzinga Cosmos Health Receives Nasdaq Notice on Late Filing of Its Form 10-K April 19, 2024 Via ACCESSWIRE Cosmos Health Commences Development of Cloudscreen 2.0, the New Iteration of its Next Generation AI Drug Repurposing Platform March 21, 2024 Via ACCESSWIRE Cosmos Health To Receive Regulatory Approval for C-Scrub Disinfectant in the UK, Obtains Initial Purchase Order; Explores Opportunities Outside EU, Eyeing Global $36Bn+ Market March 19, 2024 Via ACCESSWIRE Cosmos Health Receives Regulatory Approval to Sell Sky Premium Life Products in $1.9Bn UAE Nutritional Supplements Market; Secures Initial Purchase Orders March 18, 2024 Via ACCESSWIRE Cosmos Health Successfully Completes Acquisition of Pharmatrade’s Assets; Expects to Increase FY 2024 Annual Revenue by over $5 Million February 29, 2024 Via ACCESSWIRE Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.